Feasibility and Effects of Valaciclovir Treatment in Persons With Early Alzheimer's Disease
Status:
Completed
Trial end date:
2020-03-04
Target enrollment:
Participant gender:
Summary
This study investigates the effects of Valaciclovir treatment to individuals with Alzheimer's
disease or Mild Cognitive Impairment of Alzheimer's Disease Type. It is an open pilot trial
where 36 participants will receive 4 weeks of Valaciclovir treatment. Participants will be
investigated using different measures before and after the treatment period.